BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31492910)

  • 1. Integrating SpyCatcher/SpyTag covalent fusion technology into phage display workflows for rapid antibody discovery.
    Fierle JK; Abram-Saliba J; Brioschi M; deTiani M; Coukos G; Dunn SM
    Sci Rep; 2019 Sep; 9(1):12815. PubMed ID: 31492910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SpyDisplay: A versatile phage display selection system using SpyTag/SpyCatcher technology.
    Kellmann SJ; Hentrich C; Putyrski M; Hanuschka H; Cavada M; Knappik A; Ylera F
    MAbs; 2023; 15(1):2177978. PubMed ID: 36803166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system.
    Alam MK; Brabant M; Viswas RS; Barreto K; Fonge H; Ronald Geyer C
    BMC Biotechnol; 2018 Sep; 18(1):55. PubMed ID: 30200951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of Antibody Fragments for CAR-T Cell Therapy from Phage Display Libraries.
    Leyton-Castro NF; Brigido MM; Maranhão AQ
    Methods Mol Biol; 2020; 2086():13-26. PubMed ID: 31707665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody.
    Choi JR; Kim MJ; Tae N; Wi TM; Kim SH; Lee ES; Kim DH
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32630442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human and rabbit recombinant antibodies for the detection of Zearalenone by phage display antibody technology.
    Sompunga P; Pruksametanan N; Rangnoi K; Choowongkomon K; Yamabhai M
    Talanta; 2019 Aug; 201():397-405. PubMed ID: 31122440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Phage Display.
    Shim H
    Adv Exp Med Biol; 2017; 1053():21-34. PubMed ID: 29549633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of single chain antibody fragments binding to the extracellular domain of 4-1BB receptor by phage display technology.
    Bagheri S; Yousefi M; Safaie Qamsari E; Riazi-Rad F; Abolhassani M; Younesi V; Dorostkar R; Movassaghpour AA; Sharifzadeh Z
    Tumour Biol; 2017 Mar; 39(3):1010428317695924. PubMed ID: 28347235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Array-in-well binding assay for multiparameter screening of phage displayed antibodies.
    Pérez-Gamarra S; Hattara L; Batra G; Saviranta P; Lamminmäki U
    Methods; 2017 Mar; 116():43-50. PubMed ID: 27956240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.
    Tohidkia MR; Asadi F; Barar J; Omidi Y
    BioDrugs; 2013 Feb; 27(1):55-67. PubMed ID: 23344946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of phage display to generate conformation-sensor recombinant antibodies.
    Haque A; Tonks NK
    Nat Protoc; 2012 Dec; 7(12):2127-43. PubMed ID: 23154784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection and characterization of human serum albumin-specific porcine scFv antibodies using a phage display library.
    Muraoka J; Ozawa T; Enomoto Y; Kiyose N; Imamura A; Arima K; Nakayama H; Ito Y
    Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):42-8. PubMed ID: 24555936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
    Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
    J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual display: phage selection driven by co-engagement of two targets by two different antibody fragments.
    Fagète S; Botas-Perez L; Rossito-Borlat I; Adea K; Gueneau F; Ravn U; Rousseau F; Kosco-Vilbois M; Fischer N; Hartley O
    Protein Eng Des Sel; 2017 Sep; 30(9):575-582. PubMed ID: 28444391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of human single-chain fragment antibody (ScFv) against human epidermal growth factor receptor-2 (HER-2) by phage display technology.
    Foroumadi S; Rajabibazl M; Rahimpour A; Shahidi S; Ebrahimizadeh W; Yarahmadi M; Rajabi S; Daraei A
    In Vitro Cell Dev Biol Anim; 2018 Feb; 54(2):85-91. PubMed ID: 29305748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.
    Rossant CJ; Carroll D; Huang L; Elvin J; Neal F; Walker E; Benschop JJ; Kim EE; Barry ST; Vaughan TJ
    MAbs; 2014; 6(6):1425-38. PubMed ID: 25484064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.
    Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B
    PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA' fusions on live bacteria.
    Benhar I; Azriel R; Nahary L; Shaky S; Berdichevsky Y; Tamarkin A; Wels W
    J Mol Biol; 2000 Aug; 301(4):893-904. PubMed ID: 10966794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of antibody fragments by yeast display.
    Scholler N
    Methods Mol Biol; 2012; 907():259-80. PubMed ID: 22907357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.